PATENT CLAIM ANALYSIS

Application Number: 15869549
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["435", "195000"]

Abstract:
This invention provides compositions of active highly phosphorylated lysosomal sulfatase enzymes, their pharmaceutical compositions, methods of producing and purifying such lysosomal sulfatase enzymes and compositions and their use in the diagnosis, prophylaxis, or treatment of diseases and conditions, including particularly lysosomal storage diseases that are caused by, or associated with, a deficiency in the lysosomal sulfatase enzyme.

Claim (Index 22):
A method of treating a subject suffering from a deficiency of a lysosomal sulfatase enzyme comprising administering to the subject in need of said lysosomal sulfatase enzyme a therapeutically effective amount of said lysosomal sulfatase enzyme, wherein said lysosomal sulfatase enzyme is a recombinant human lysosomal sulfatase enzyme or biologically active fragment, mutant, variant or derivative thereof produced by a CHO-derived ENDS complementation group cell or a derivative thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.58537
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12355453', '14281538', '13188907', '14573907', '14924405']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.744430933582032
- 35 USC 102 Novelty (BERT): 0.6591649219374662
- Combined Prediction Score: 0.7359043324175755
- Mean Citation Score: 709.8492980000003
- Max Citation Score: 756.8287
- Similarity Product: 603.7484540274262

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test